ScholarIQanswers from OpenAlex
Mitsubishi Group (Japan)
InstitutionResearch output, impact & collaborations
Mitsubishi Group (Japan) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Mitsubishi Group (Japan)?
ScholarIQrecord summary
Mitsubishi Group (Japan) is a research organisation in Tokyo, JP. OpenAlex records 9,246 works and 697,429 citations for it. 1,926 researchers list it as their most recent affiliation.
How many works does Mitsubishi Group (Japan) have?
ScholarIQindexed works
Mitsubishi Group (Japan) has 9,246 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mitsubishi Group (Japan) have?
ScholarIQcitation count
Mitsubishi Group (Japan) has 697,429 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Mitsubishi Group (Japan)?
ScholarIQresearcher count
Mitsubishi Group (Japan) has 1,926 researchers in the ScholarIQ index.
What is the average h-index at Mitsubishi Group (Japan)?
ScholarIQavg h-index
Mitsubishi Group (Japan) has an average h-index of 8.5 in OpenAlex.
What is the ROR of Mitsubishi Group (Japan)?
ScholarIQror
The ROR for Mitsubishi Group (Japan) is on the source record.
What is the OpenAlex record for Mitsubishi Group (Japan)?
ScholarIQopenalex
The OpenAlex for Mitsubishi Group (Japan) is on the source record.
Who are the most-cited researchers behind Mitsubishi Group (Japan)?
ScholarIQtop researchers by citations
What are the most-cited papers on Mitsubishi Group (Japan)?
ScholarIQmost cited works
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Masahiko Tanaka, Makoto Akimoto, Kazue Nakamura, Fumihiro Takahashi, Kazuoki Kondo, Hiide Yoshino, Koji Abe, Masashi Aoki, Shoji Tsuji, Yasuto Itoyama, Gen Sobue, Masanori Togo, Chikuma Hamada, Hidenao Sasaki, Ichiro Yabe, Shizuki Doi, Hitoshi Warita, Takashi Imai, Hiroaki Ito, Mitsumasa Fukuchi, Etsuko Osumi, Manabu Wada, Imaharu Nakano, Mitsuya Morita, Katsuhisa Ogata, Yuichi Maruki, Kimiko Ito, Osamu Kano, Mineo Yamazaki, Yuji Takahashi, Hiroyuki Ishiura, Mieko Ogino, Ryoko Koike, Chiho Ishida, Tsuyoshi Uchiyama, Kouichi Mizoguchi, Tomokazu Obi, Hirohisa Watanabe, Naoki Atsuta, Ikuko Aiba, Akira Taniguchi, Hideyuki Sawada, Takanori Hazama, Harutoshi Fujimura, Hirofumi Kusaka, Takenobu Kunieda, Hitoshi Kikuchi, Hidenori Matsuo, Hidetsugu Ueyama, Kazutoshi Uekawa, Masahiko Tanaka, Makoto Akimoto, Masaki Ueda, Aiko Murakami, Rie Sumii, Takuya Kudou, Kazue Nakamura, K. Morimoto, Takatomo Yoneoka, Manabu Hirai, Kouichi Sasaki, H. Terai, Tomoko Natori, Hiroshi Matsui, Kuniko Kotani, Kaori Yoshida, Tomohisa Iwasaki, Fumihiro Takahashi, Kazuoki Kondo, Hiide Yoshino
Regulation of cell-cell contacts in developing Drosophila eyes by Dsrc41, a new, close relative of vertebrate c-src.
Fumihiro Takahashi, Satoshi Endo, Tetsuya Kojima, K. Saigo
Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
Jeremy M. Shefner, Terry Heiman‐Patterson, Erik P. Pioro, Martina Wiedau‐Pazos, X. Shawn Liu, Jeffrey Zhang, Wendy Agnese, Stephen Apple
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19
Ammar Al‐Chalabi, Adriano Chiò, Charlotte Merrill, Gerry Oster, Rebecca Bornheimer, Wendy Agnese, Stephen Apple
An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe
Koji Takei, Kikumi Tsuda, Fumihiro Takahashi, Manabu Hirai, Joseph Palumbo
How much of the research on Mitsubishi Group (Japan) is open access?
ScholarIQopen access share
92%OPEN ACCESS